Skip to main content
. 2022 Apr 21;20:21. doi: 10.1186/s12959-022-00380-4

Fig. 1.

Fig. 1

Distribution of ticagrelor platelet inhibiting rate measured by TEG in ACS patients. A and B represent the distribution of ADP% measured by TEG in derivation and validation group, respectively. C represent the distribution of ADP% in all included patients. ACS: acute coronary syndrome; ADP%: ADP-induced platelet inhibition rate; TEG: thromboelastography